Day Jon I, Allen-Moyer Katherine N, Cole Kevin P
Synthetic Molecule Design and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
Statistics - Discovery/Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285. Current: Social and Scientific Systems, Inc., A DLH Holdings Corp. Company, Durham, North Carolina 27703, United States.
J Org Chem. 2023 Apr 7;88(7):4209-4223. doi: 10.1021/acs.joc.2c02771. Epub 2023 Mar 23.
Within the scope of developing a new route to an active pharmaceutical ingredient intermediate, we had need of a fluorinated indazole. Although an established route was in place, it was undesirable due to safety and selectivity concerns. A concise and improved route was developed to form the desired indazole, which takes advantage of an electronically directed metalation/formylation sequence followed by condensation with methyl hydrazine to form a hydrazone and culminates in a copper-catalyzed intramolecular Ullmann cyclization. The Ullmann reaction was plagued with difficulties ranging from poor reactivity to thermal hazard concerns, but use of high-throughput screening, statistical modeling, and an unusual isolation method for fine chemicals, safe and optimal conditions were found that produce high-purity isolated material in excellent yields at a laboratory scale.
在开发一种活性药物成分中间体新路线的过程中,我们需要一种氟化吲唑。尽管已有一条既定路线,但出于安全和选择性方面的考虑,它并不理想。我们开发了一条简洁且改进的路线来合成所需的吲唑,该路线利用了电子导向的金属化/甲酰化序列,随后与甲基肼缩合形成腙,并最终通过铜催化的分子内乌尔曼环化反应完成。乌尔曼反应面临着从反应性差到热危害等诸多困难,但通过使用高通量筛选、统计建模以及一种用于精细化学品的特殊分离方法,我们找到了安全且优化的条件,能够在实验室规模下以优异的产率生产出高纯度的分离产物。